HUTCHMED (China) (HCM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on HUTCHMED (China) (HCM) is Neutral.

The composite score behind that read is +0.15, weighing +0.23 of bullish evidence against -0.14 bearish.

HUTCHMED (China) last closed at $14.10, +3.15% on the session.

Against the IVW growth benchmark the position is +2.35% over the forecast window.

The read is built from 15 underlying insights — 6 bullish and 9 bearish.

Agreement across those insights is 40%.

2 graded predictions for HCM so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

HUTCHMED (China) is classified under Health Care / Pharmaceuticals, with a market capitalisation of $2.38B.

StockMap tracks HUTCHMED (China) as the 36th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite HUTCHMED (China) ranks 22nd of 151 in the group, against a group median of -0.08.